Literature DB >> 18977602

Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling.

Olivia F O'Leary1, Xuefei Wu, Eero Castren.   

Abstract

Antidepressant drugs have been suggested to regulate synaptic transmission and structure. We hypothesised that antidepressant-induced changes in synapses and their associated proteins might become more apparent if they were measured under conditions of reduced synapse density. Therefore, in the present study, we examined whether chronic treatment with the antidepressant, fluoxetine alters expression of synaptic proteins in the hippocampus of rodents that underwent ovariectomy, a procedure which reportedly decreases synapse density in the CA1 region of the rat hippocampus. Using Western blotting, we measured changes in hippocampal expression of proteins associated with synapse structure, strength and activity namely, postsynaptic density protein 95 (PSD-95), the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA-R) subunit GluR1 and phosphosynapsin (Ser9), respectively. We found that fluoxetine treatment increased expression of phosphosynapsin, PSD-95 and synaptic GluR1 (but not total GluR1) in the hippocampus of ovariectomized but not sham rats. Since BDNF and signalling at its receptor, TrkB, can mediate behavioural responses to antidepressants and induce neuronal plasticity, we investigated the contribution of TrkB signalling to fluoxetine-induced changes in synaptic protein expression by using a transgenic mouse model overexpressing a truncated form of the TrkB receptor (TrkB.T1). Fluoxetine produced a small but significant increase in hippocampal PSD-95 in ovariectomized wildtype mice but not in ovariectomized TrkB.T1 mice or sham mice. In contrast to rats, fluoxetine did not alter expression of synaptic GluR1 and did not reverse ovariectomy-induced decreases in hippocampal phosphosynapsin in either genotype. Taken together, these results suggest that chronic fluoxetine treatment can increase synaptic protein expression in the hippocampus and at least some of these effects require TrkB signalling. Moreover, these effects were only observed in ovariectomized animals, thus suggesting that fluoxetine-induced increases in synaptic protein levels might only occur or become detectable when hippocampal synaptic connectivity is perturbed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977602     DOI: 10.1016/j.psyneuen.2008.09.015

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  19 in total

1.  Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.

Authors:  Mohammad M Herzallah; Ahmed A Moustafa; Joman Y Natsheh; Omar A Danoun; Jessica R Simon; Yasin I Tayem; Mahmud A Sehwail; Ivona Amleh; Issam Bannoura; Georgios Petrides; Catherine E Myers; Mark A Gluck
Journal:  J Affect Disord       Date:  2013-08-13       Impact factor: 4.839

Review 2.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

Review 3.  Spine synapse remodeling in the pathophysiology and treatment of depression.

Authors:  Catharine H Duman; Ronald S Duman
Journal:  Neurosci Lett       Date:  2015-01-09       Impact factor: 3.046

4.  Calotropis procera attenuates chronic unpredictable mild stress-induced depression in experimental animals.

Authors:  Debapriya Garabadu; Neha Srivastava; Yogesh Murti
Journal:  Metab Brain Dis       Date:  2019-07-26       Impact factor: 3.584

5.  Estrogen receptor β deficiency impairs BDNF-5-HT2A signaling in the hippocampus of female brain: A possible mechanism for menopausal depression.

Authors:  Anindit Chhibber; Sarah K Woody; M A Karim Rumi; Michael J Soares; Liqin Zhao
Journal:  Psychoneuroendocrinology       Date:  2017-05-18       Impact factor: 4.905

6.  Functional interactions between steroid hormones and neurotrophin BDNF.

Authors:  Tadahiro Numakawa; Daisaku Yokomaku; Misty Richards; Hiroaki Hori; Naoki Adachi; Hiroshi Kunugi
Journal:  World J Biol Chem       Date:  2010-05-26

7.  Selective deletion of a cell cycle checkpoint kinase (ATR) reduces neurogenesis and alters responses in rodent models of behavioral affect.

Authors:  Jennifer L Onksen; Eric J Brown; Julie A Blendy
Journal:  Neuropsychopharmacology       Date:  2011-01-19       Impact factor: 7.853

8.  Melanocortin 4 receptor stimulation prevents antidepressant-associated weight gain in mice caused by long-term fluoxetine exposure.

Authors:  María José Ortuño; Marc Schneeberger; Anoj Ilanges; François Marchildon; Kyle Pellegrino; Jeffrey M Friedman; Patricia Ducy
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

9.  BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice.

Authors:  Li-Tao Yi; Jing Li; Bin-Bin Liu; Liu Luo; Qing Liu; Di Geng
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

Review 10.  Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.

Authors:  Eero Castrén; Tomi Rantamäki
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.